Disel U - Search Results

1

The prevalence of depression in patients with cancer in Jordan.

Kose F, Abali H, Besen A, Disel U, Hayran M. Kose F, et al. Among authors: disel u. Support Care Cancer. 2010 Jun;18(6):657-8. doi: 10.1007/s00520-010-0842-9. Epub 2010 Apr 8. Support Care Cancer. 2010. PMID: 20376503 No abstract available.

2

Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors.

Abali H, Sezer A, Oğuzkurt L, Gürel K, Özkan U, Beşen AA, Sümbül AT, Köse F, Dişel U, Muallaoğlu S, Özyılkan Ö. Abali H, et al. Among authors: disel u. Support Care Cancer. 2013 Apr;21(4):1131-5. doi: 10.1007/s00520-012-1636-z. Epub 2012 Nov 8. Support Care Cancer. 2013. PMID: 23132146

3

Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study.

Dişel U, Beşen A, Karadeniz C, Mertsoylu H, Sezer A, Köse F, TanerSümbül A, Gürkut O, Muallaoğlu S, Abali H, Ozyilkan O. Dişel U, et al. Med Oncol. 2012 Dec;29(5):3608-13. doi: 10.1007/s12032-012-0254-4. Epub 2012 May 22. Med Oncol. 2012. PMID: 22729367

4

Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.

Kose F, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Altundag O, Ozyilkan O. Kose F, et al. Among authors: disel u. Asian Pac J Cancer Prev. 2011;12(5):1185-8. Asian Pac J Cancer Prev. 2011. PMID: 21875263 Free article.

5

Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?

Abali H, Disel U, Köse F, Sezer A, Mertsoylu H. Abali H, et al. Among authors: disel u. J Clin Oncol. 2009 Jun 10;27(17):2889; author reply 2889. doi: 10.1200/JCO.2009.22.3305. Epub 2009 Apr 27. J Clin Oncol. 2009. PMID: 19398567 No abstract available.

6

Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.

Kose F, Oguzkurt L, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Mertsoylu H, Ozyilkan O. Kose F, et al. Among authors: disel u. Eur J Radiol. 2012 Aug;81(8):1724-7. doi: 10.1016/j.ejrad.2011.04.056. Epub 2011 May 18. Eur J Radiol. 2012. PMID: 21596502

7

Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.

Kose F, Abali H, Sezer A, Mertsoylu H, Disel U, Ozyilkan O. Kose F, et al. Among authors: disel u. Leuk Lymphoma. 2009 Feb;50(2):282-3. doi: 10.1080/10428190802603169. Leuk Lymphoma. 2009. PMID: 19197737 No abstract available.

8

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Dişel U, Oztuzcu S, Beşen AA, Karadeniz C, Köse F, Sümbül AT, Sezer A, Nursal GN, Abalı H, Ozyılkan O. Dişel U, et al. Lung Cancer. 2011 Jan;71(1):109-12. doi: 10.1016/j.lungcan.2010.09.011. Lung Cancer. 2011. PMID: 20970876

9

Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience.

Kose F, Abali H, Sezer A, Ali Besen A, Taner Sumbul A, Karadeniz C, Disel U, Ozyilkan U. Kose F, et al. Among authors: disel u. J BUON. 2011 Jul-Sep;16(3):469-72. J BUON. 2011. PMID: 22006752

10

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Sümbül AT, Dişel U, Sezgin N, Sezer A, Köse F, Beşen AA, Sümbül Z, Abalı H, Özyılkan Ö. Sümbül AT, et al. Among authors: disel u. Med Sci Monit. 2014 Mar 15;20:428-33. doi: 10.12659/MSM.889945. Med Sci Monit. 2014. PMID: 24632679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters